About this document

Duphaston Brand Strategy 2023 Overview by Shantanu Bhattacharya is a document available to read on EtoBox.

Duphaston, the leading brand for progesterone deficiency, aims for $47.4 million in sales in 2023, targeting a 19.5% growth despite increasing generic competition. The brand faced challenges in 2022 due to the entry of numerous generics and the impact of the ART Bill on IVF cycles, leading to a decline in gynecology sales. To counteract these challenges, Duphaston plans to increase marketing support and expedite new product launches.

Author

Shantanu Bhattacharya

Language

EN